Sorrento Therapeutics Inc
0.00 (0.0%)


Draw Mode:

Volume 0
Bid Price 0.271
Ask Price 0.2748
News -
Day High


52 Week Range


Day Low
Company Name Stock Ticker Symbol Market Type
Sorrento Therapeutics Inc SRNE NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 0.3073 20:00:00
Open Price Low Price High Price Close Price Prev Close
Trades Volume Avg Volume 52 Week Range
0 0 - 0.161 - 3.09
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 0.3073 USD

Sorrento Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 168.36M 547.88M 543.18M $ 52.90M $ - -1.43 -0.20
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 495.00 19.90%

more financials information »

Sorrento Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No SRNE Message Board. Create One! See More Posts on SRNE Message Board See More Message Board Posts

Historical SRNE Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.
1 Month0.
3 Months1.131.230.1610.414109852,397,082-0.8227-72.81%
6 Months1.611.890.1610.62290923,309,970-1.30-80.91%
1 Year2.463.090.1611.0915,799,021-2.15-87.51%
3 Years1.8721.260.1616.1916,300,506-1.56-83.57%
5 Years7.2021.260.1615.9310,788,693-6.89-95.73%

Sorrento Therapeutics Description

Sorrento Therapeutics Inc is a biotechnology company focused on the development of novel immunotherapies for oncology and autoimmune/inflammation diseases. The antibody technologies target various locations: extracellular, intracellular, and membrane-bound antigens. The product portfolio consists of BioSimilar/BioBetter antibodies, CAR-T programs for the treatment of solid tumors, adoptive cellular therapies, immuno-oncology mAbs, and antibody-drug conjugates.